MPM Capital

MPM Capital

Type	Private
Industry	Venture Capital
Founded	1992 established as an advisory firm 1996 established as a venture capital firm
Headquarters	Boston, Massachusetts and San Francisco California, United States
Products	Venture Capital and Crossover Funds
Total assets	$2.5 billion in assets under management
Number of employees	30+
Website	www.mpmcapital.com

MPM Capital – Powering Breakthroughs in Life Sciences

MPM is an early-stage life sciences venture investing firm with a track record of identifying and building world-class companies that seek to cure major diseases by translating scientific innovations into positive clinical outcomes. MPM’s diversified and active portfolio of companies aims to revolutionize the face of medicine across multiple areas including cancer, diabetes, obesity, pain, eHealth and more. With its deep experience, dedicated team of operating executives, and distinguished medical and scientific advisory board, MPM is powering novel medical breakthroughs that transform patient lives.

Investment Approach

MPM is currently investing more than $870 million in funds from both its BioVentures 2014 fund and its 2016 UBS Oncology Impact Fund (OIF). As an oncology-only, evergreen, crossover fund , the OIF aims to make a positive social impact beyond financial returns. MPM has dedicated a portion of its own profits from the OIF to provide access to cancer care in the developing world and, in collaboration with the American Association for Cancer Research, to identify and fund promising academic cancer research.

Investment funds (as of July 2016)

UBS Oncology Impact Fund (OIF)]^[1] – raised in partnership with UBS in 2016. Managed by MPM, the fund is focused exclusively on oncology comprising private and public investments with an impact component that funds cancer research and access to cancer care.
MPM BioVentures (BV2014) – raised in 2014, invests in early stage in any therapeutic area but oncology predominates. The fund focuses on early stage investors and company building.
MPM BioVentures 2010 – raised in 2010, invested in a portfolio of 18 companies.
MPM BioVentures 2006 – raised in 2006, invested in a portfolio of 27 companies.
MPM BioVentures III – raised in 2002, invested in a portfolio of 39 companies.
MPM BioVentures II – raised in 2000,invested in a portfolio of 35 companies.
MPM BioVentures I – raised in 1997, invested in a portfolio of 26 companies.

References

↑ UBS, MPM seek big 'impact' in cancer drugs with $471M fund. BioWorld, Retrieved 6-30-2016

External links

MPM Capital (company website)
MPM Capital Press Coverage (company website)

Private equity and venture capital investment firms

Investment strategy	Venture Growth Mezzanine Secondaries Leveraged buyout

History	History of private equity and venture capital Early history of private equity Private equity in the 1980s Private equity in the 1990s Private equity in the 2000s

Investors	Angel investor Corporate venture capital Commercial bank Crowdfunding Institutional investor Insurance company Investment bank Endowment Family office Fund of funds High-net-worth individual Merchant bank Pension fund Sovereign wealth fund

Private equity firms Venture capital firms Portfolio companies

This article is issued from Wikipedia - version of the 7/23/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.